breast-neoplasms

Documents about breast-neoplasms

• DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the Breast#858251ClinicalTrials.gov
• Implementation of Quality of Life Diagnostics and Therapy#885766ClinicalTrials.gov
• Assessment of Oncological Safety, Quality of Life, and Environmental Impact of the Green Breast Surgery Protocol#982627ClinicalTrials.gov
• CT-AI Breast Cancer Opportunistic Screening Health Examination Study#839936ClinicalTrials.gov
• DIEP-MDS for Risk Stratification of Flap Vascular Compromise and Failure in Breast Reconstruction#852438ClinicalTrials.gov
• Application of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction Patients#888055ClinicalTrials.gov
• Slow Jogging for Breast Cancer Survivors#967531ClinicalTrials.gov
• Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy#123570ClinicalTrials.gov
• Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study#994982ClinicalTrials.gov
• A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors#405118ClinicalTrials.gov
• Minimal Access Versus Conventional Latissimus Dorsi Flap Harvest for Breast Reconstruction#828217ClinicalTrials.gov
• Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer#831994ClinicalTrials.gov
• Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin#836887ClinicalTrials.gov
• A Study of Trastuzumab Subcutaneous in Participants With Human Epidermal Growth Factor Receptor-2 (HER2) Positive Early Breast Cancer#848299ClinicalTrials.gov
• The Efficacy of Acupuncture as a Complementary Treatment for Pain and Anxiety After Breast Cancer Surgery#864178ClinicalTrials.gov
• A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer#875015ClinicalTrials.gov
• Massage Therapy for Cancer-Related Fatigue#871774ClinicalTrials.gov
• ZMIZ1 enhances ERα-dependent expression of E2F2 in breast cancer.#317183Apollo
• Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer#852099ClinicalTrials.gov
• A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.#852329ClinicalTrials.gov
• Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer#982722ClinicalTrials.gov
• Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer#898458ClinicalTrials.gov
• Complete decongestive therapy for breast cancer-related lymphedema: An evidence summary#676298Europe PMC
• The epidemiology of Her-2/neu and P53 in breast cancer#679994Redalyc
• Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer#867424ClinicalTrials.gov
• Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer#918763ClinicalTrials.gov
• A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer#875166ClinicalTrials.gov
• Diffusion Coefficient and Micro-calcifications to Kaiser Score in Evaluation of BI-RADS 4 Breast Lesions#828460ClinicalTrials.gov
• Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave), NEOELASTO#879850ClinicalTrials.gov
• Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy#234493ClinicalTrials.gov
• Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen#876684ClinicalTrials.gov
• Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion#234422ClinicalTrials.gov
• Gene-expression profiles in hereditary breast cancer#348142Lund University Publications
• Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast#865728ClinicalTrials.gov
• Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib#1032325ClinicalTrials.gov
• Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency#842302ClinicalTrials.gov
• CYP2D6 Genotype on the Clinical Effect of Tamoxifen#857526ClinicalTrials.gov
• Study Evaluating HKI-272 in Tumors#862005ClinicalTrials.gov
• Evaluation of Cryoprotection Induced Nail Toxicity Docetaxel Low Cumulative Dose#884232ClinicalTrials.gov
• Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host#968257ClinicalTrials.gov
• The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer#800289ClinicalTrials.gov
• ESPB and RIB for Pain Management Following Mastectomy Surgery#885958ClinicalTrials.gov
• Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients#890789ClinicalTrials.gov
• Exclusive Intraoperative Radiation Therapy for Breast Cancer#915040ClinicalTrials.gov
• Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC)#966886ClinicalTrials.gov
• Women's Health Initiative (WHI)#835330ClinicalTrials.gov
• A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer#127592ClinicalTrials.gov
• Diagnostic Utility of MRI in Female Patients With Nipple Discharge: A Prospective Trial#859141ClinicalTrials.gov
• Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients#864509ClinicalTrials.gov
• A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCs#981812ClinicalTrials.gov